aztreonam and Bacterial Disease studies

Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.

Research Excerpts

Excerpt	Relevance	Reference
" In the present study, we chose aztreonam as the alternative to aminoglycoside in combination with piperacillin for neutropenic fever in pediatric patients and we evaluated its effectiveness."	9.10	Piperacillin plus aztreonam for treatment of neutropenic fever. ( Mayumi, M; Takeuchi, M; Tanizawa, A, 2003)
"Fourty-two febrile episodes of 32 patients with hematologic disease during neutropenia were treated with two randomly assigned antibiotic combinations of either piperacillin plus gentamicin or piperacillin plus aztreonam."	9.07	[Aztreonam or gentamicin combined with piperacillin as empiric antibiotic therapy during neutropenia of patients with hematologic diseases]. ( Murase, T, 1992)
"One hundred ninety-one US students with diarrhea acquired in Mexico received 100 mg of aztreonam or matching placebo three times a day for 5 days."	9.07	Oral aztreonam, a poorly absorbed yet effective therapy for bacterial diarrhea in US travelers to Mexico. ( Conrad, DA; de la Cabada, FJ; DuPont, HL; Ericsson, CD; Mathewson, JJ, 1992)
"Forty six patients who developed 48 episodes of peritonitis while on CAPD were randomised to receive either oral ofloxacin or intraperitoneal (i."	9.07	A randomised prospective comparison of oral ofloxacin and intraperitoneal vancomycin plus aztreonam in the treatment of bacterial peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD). ( Chan, CY; Cheng, IK; Wong, WT, 1991)
"Aztreonam and cefotaxime were compared in 44 cirrhotic patients who had 52 episodes of gram-negative spontaneous peritonitis."	9.07	Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients. ( Alonso, T; Ariza, J; Esteve, M; Fernández Bañeres, F; Gudiol, F; Liñares, J; Xiol, X, 1991)
"In a prospective randomized, open study we evaluated aztreonam (AZ) for treatment of neonatal bacterial infections."	9.06	Evaluation of aztreonam and ampicillin vs. amikacin and ampicillin for treatment of neonatal bacterial infections. ( Castro, E; McCracken, GH; Odio, CM; Salas, JL; Umaña, MA, 1990)
"A multicenter comparative study was carried out to evaluate the efficacy of aztreonam and gentamicin in 186 patients with symptomatic renal or urinary tract infections."	9.06	Multicenter comparative study of aztreonam and gentamicin in the treatment of renal and urinary tract infections. ( Albertazzi, A; Bonadio, M; Fusaroli, M; Lotti, T; Miano, L; Salvia, G; Sasdelli, M; Ventriglia, L; Villa, G; Zucchelli, P, 1989)
"A multicenter trial involving several urologic units in Italy provided pooled data on 1,427 patients with urinary tract infections to evaluate the efficacy and safety of aztreonam, a new monobactam antibiotic."	9.06	Aztreonam in the treatment of urinary tract infections: a multicenter trial. ( Cortecchia, V; Martelli, A; Ventriglia, L, 1989)
"Aztreonam (AZT) (2 g daily) was intravenously administered for 5 to 7 days to 65 patients with complicated urinary tract infections (UTI)."	9.06	[Clinical efficacy of aztreonam in patients with complicated urinary tract infections]. ( Kageyama, Y; Kobayashi, N; Kura, N; Nakame, Y; Negishi, T; Saitoh, H; Suwata, J; Uchijima, Y; Yamada, T; Yoshida, K, 1988)
"During the course of one year, 47 critical care patients with gram-negative bacillary pneumonia at Millard Fillmore Hospital were randomly assigned to aztreonam or tobramycin therapy (two to one)."	9.05	Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia. ( Schentag, JJ; Simons, GW; Smith, IL; Swanson, DJ; Vari, AJ; Vigano, A; Winslade, NE, 1985)
" We evaluated the efficacy of a combined antibiotic regimen of monobactam (aztreonam) and antipseudomonal penicillin (piperacillin) in treating neutropenic fever episodes in gynecologic-oncology patients receiving cisplatin-based chemotherapy."	7.70	Aztreonam plus piperacillin--empiric treatment of neutropenic fever in gynecology-oncology patients receiving cisplatin-based chemotherapy. ( Altaras, M; Beyth, Y; Chowers, M; Fishman, A; Lang, R, 1998)
"10 patients with meningitis due to unusual gram-negative organisms (Pseudomonas, Proteus, Salmonella and Klebsiella) were effectively treated with aztreonam."	7.68	Aztreonam for treating meningitis caused by gram-negative rods. ( Bishay, E; Farid, Z; Girgis, N; Kilpatrick, M, 1991)
"The monobactam aztreonam was used to treat 22 young patients with meningitis caused by gram-negative bacilli."	7.67	Aztreonam in the treatment of bacterial meningitis. ( Ayroza-Galvão, PA; Barbosa Júnior, SP; Cavalcante, NJ; Lorenco, R; Maassen, S; Martino, MD; Milstein-Kuschnaroff, TM; Mimica, IM; Mimica, LM, 1989)
"A combination of aztreonam (AZT) and clindamycin (CLDM) was evaluated for severe infections associated with leukemia and related disorders."	7.67	[Clinical evaluation of a combination therapy with aztreonam and clindamycin for severe infections in leukemia and related disorders]. ( Abe, T; Horiike, S; Inazawa, J; Misawa, S; Nakagawa, H; Nishigaki, H; Okuda, T; Tanaka, S; Taniwaki, M; Tsuda, S, 1989)
"A noncomparative pilot study was conducted to assess the potential usefulness of aztreonam in pulmonary exacerbations of cystic fibrosis."	7.67	Efficacy of aztreonam in pulmonary exacerbations of cystic fibrosis. ( Black, PG; Bosso, JA; Matsen, JM, 1987)
"Nineteen patients with community- or hospital-acquired gram-negative pneumonia were treated with aztreonam."	7.67	Aztreonam therapy for gram-negative pneumonia. ( Bollinger, M; Greenberg, RN; Luppen, KL; McMillian, R; Reilly, PM, 1985)
"Aztreonam therapy was evaluated for the management of 80 patients with gram-negative bacilli lower respiratory tract infections."	7.67	Efficacy and safety of aztreonam versus tobramycin for aerobic gram-negative bacilli lower respiratory tract infections. ( Ramirez-Ronda, CH; Rodriguez, JR, 1985)
"Gram-negative pneumonia is a frequent complication in hospitalized patients, particularly in those with diminished defenses."	6.66	Comparative study of aztreonam in gram-negative pneumonia versus a therapeutic regimen that includes an aminoglycoside. Spanish Study Group. ( Gobernado, M; Marco, V; Rabinad, E; Santos, M, 1989)
"Carumonam is a new monobactam antibiotic with potent activity against gram-negative aerobes."	6.66	Carumonam versus ceftazidime for urinary tract infections. ( Cassano, K; Edelstein, H; McCabe, R; Oster, S, 1988)
"Aztreonam was well tolerated."	5.28	Efficacy and safety of low dose aztreonam in the treatment of moderate to severe gram-negative bacterial infections. ( Carbon, C; Clergeot, A; Rosset, MA; Steru, D, 1989)
"Aztreonam was used in the initial treatment of infection of the urinary tract (23 cases), respiratory tract (17 cases), skin and soft tissue (12 cases), abdominal cavity (three cases), endocarditis (two cases), septicemia (eight cases), and osteomyelitis (two cases)."	5.27	Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections. ( Chandrasekar, P; Kannangara, W; LeFrock, JL; Molavi, A; Rolston, KV; Smith, BR, 1987)
"Aztreonam seems to be an effective single agent therapy for many bacterial infections."	5.27	Evaluation of aztreonam in the treatment of severe bacterial infections. ( Bouza, E; García de la Torre, M; Guerrero, A; Hellín, T; Martínez-Beltrán, J; Rodríguez-Créixems, M; Romero-Vivas, J, 1985)
" In the present study, we chose aztreonam as the alternative to aminoglycoside in combination with piperacillin for neutropenic fever in pediatric patients and we evaluated its effectiveness."	5.10	Piperacillin plus aztreonam for treatment of neutropenic fever. ( Mayumi, M; Takeuchi, M; Tanizawa, A, 2003)
"Fourty-two febrile episodes of 32 patients with hematologic disease during neutropenia were treated with two randomly assigned antibiotic combinations of either piperacillin plus gentamicin or piperacillin plus aztreonam."	5.07	[Aztreonam or gentamicin combined with piperacillin as empiric antibiotic therapy during neutropenia of patients with hematologic diseases]. ( Murase, T, 1992)
"One hundred ninety-one US students with diarrhea acquired in Mexico received 100 mg of aztreonam or matching placebo three times a day for 5 days."	5.07	Oral aztreonam, a poorly absorbed yet effective therapy for bacterial diarrhea in US travelers to Mexico. ( Conrad, DA; de la Cabada, FJ; DuPont, HL; Ericsson, CD; Mathewson, JJ, 1992)
"Forty six patients who developed 48 episodes of peritonitis while on CAPD were randomised to receive either oral ofloxacin or intraperitoneal (i."	5.07	A randomised prospective comparison of oral ofloxacin and intraperitoneal vancomycin plus aztreonam in the treatment of bacterial peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD). ( Chan, CY; Cheng, IK; Wong, WT, 1991)
"Aztreonam and cefotaxime were compared in 44 cirrhotic patients who had 52 episodes of gram-negative spontaneous peritonitis."	5.07	Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients. ( Alonso, T; Ariza, J; Esteve, M; Fernández Bañeres, F; Gudiol, F; Liñares, J; Xiol, X, 1991)
"In a prospective randomized, open study we evaluated aztreonam (AZ) for treatment of neonatal bacterial infections."	5.06	Evaluation of aztreonam and ampicillin vs. amikacin and ampicillin for treatment of neonatal bacterial infections. ( Castro, E; McCracken, GH; Odio, CM; Salas, JL; Umaña, MA, 1990)
"A multicenter comparative study was carried out to evaluate the efficacy of aztreonam and gentamicin in 186 patients with symptomatic renal or urinary tract infections."	5.06	Multicenter comparative study of aztreonam and gentamicin in the treatment of renal and urinary tract infections. ( Albertazzi, A; Bonadio, M; Fusaroli, M; Lotti, T; Miano, L; Salvia, G; Sasdelli, M; Ventriglia, L; Villa, G; Zucchelli, P, 1989)
"A multicenter trial involving several urologic units in Italy provided pooled data on 1,427 patients with urinary tract infections to evaluate the efficacy and safety of aztreonam, a new monobactam antibiotic."	5.06	Aztreonam in the treatment of urinary tract infections: a multicenter trial. ( Cortecchia, V; Martelli, A; Ventriglia, L, 1989)
"Aztreonam (AZT) (2 g daily) was intravenously administered for 5 to 7 days to 65 patients with complicated urinary tract infections (UTI)."	5.06	[Clinical efficacy of aztreonam in patients with complicated urinary tract infections]. ( Kageyama, Y; Kobayashi, N; Kura, N; Nakame, Y; Negishi, T; Saitoh, H; Suwata, J; Uchijima, Y; Yamada, T; Yoshida, K, 1988)
"During the course of one year, 47 critical care patients with gram-negative bacillary pneumonia at Millard Fillmore Hospital were randomly assigned to aztreonam or tobramycin therapy (two to one)."	5.05	Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia. ( Schentag, JJ; Simons, GW; Smith, IL; Swanson, DJ; Vari, AJ; Vigano, A; Winslade, NE, 1985)
"Multicenter trials were conducted to determine the safety and efficacy of aztreonam in the treatment of patients with gram-negative bacterial infections."	5.05	Aztreonam: worldwide overview of the treatment of patients with gram-negative infections. ( Bendush, CB; Henry, SA, 1985)
"Endomyometritis is the most common complication associated with cesarean delivery."	3.76	Pathophysiology and management of postcesarean endomyometritis. ( Duff, P, 1986)
"Aztreonam has been effective in eradicating pseudomonal infections in most patients (except in patients with cystic fibrosis), but the inevitably limited number of pseudomonal infections available for study prevents any conclusions as to the relative efficacy of aztreonam compared with other appropriate regimens against these infections."	3.76	Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. ( Brogden, RN; Heel, RC, 1986)
"Aztreonam has excellent activity against P."	3.75	Aztreonam--an overview. ( Hopefl, AW, 1985)
" We evaluated the efficacy of a combined antibiotic regimen of monobactam (aztreonam) and antipseudomonal penicillin (piperacillin) in treating neutropenic fever episodes in gynecologic-oncology patients receiving cisplatin-based chemotherapy."	3.70	Aztreonam plus piperacillin--empiric treatment of neutropenic fever in gynecology-oncology patients receiving cisplatin-based chemotherapy. ( Altaras, M; Beyth, Y; Chowers, M; Fishman, A; Lang, R, 1998)
"10 patients with meningitis due to unusual gram-negative organisms (Pseudomonas, Proteus, Salmonella and Klebsiella) were effectively treated with aztreonam."	3.68	Aztreonam for treating meningitis caused by gram-negative rods. ( Bishay, E; Farid, Z; Girgis, N; Kilpatrick, M, 1991)
"In order to study serum concentration and urinary concentration (urinary recovery rate) of aztreonam (AZT), AZT was administered via intravenous bolus injection at dose levels of 10 mg/kg, 20 mg/kg and 50 mg/kg to 7 cases of 4 to 26 days old mature or premature infants nearing cure-stage of various bacterial infections upon the treatment with AZT."	3.68	[Pharmacokinetic and clinical evaluation of aztreonam in neonates and premature infants]. ( Kawamura, K; Nakamura, H; Seo, K; Sugita, M; Toyonaga, Y, 1990)
"Aztreonam was administered to 20 children diagnosed as having any of the following infections: urinary tract infection, pneumonia, meningitis, and abscess of the appendix."	3.67	Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients. ( Arango, A; Benítez, G; Castrillón, AL; Harry, N; Mejía, GI; Restrepo, F; Trujillo, H, 1989)
"The monobactam aztreonam was used to treat 22 young patients with meningitis caused by gram-negative bacilli."	3.67	Aztreonam in the treatment of bacterial meningitis. ( Ayroza-Galvão, PA; Barbosa Júnior, SP; Cavalcante, NJ; Lorenco, R; Maassen, S; Martino, MD; Milstein-Kuschnaroff, TM; Mimica, IM; Mimica, LM, 1989)
"A combination of aztreonam (AZT) and clindamycin (CLDM) was evaluated for severe infections associated with leukemia and related disorders."	3.67	[Clinical evaluation of a combination therapy with aztreonam and clindamycin for severe infections in leukemia and related disorders]. ( Abe, T; Horiike, S; Inazawa, J; Misawa, S; Nakagawa, H; Nishigaki, H; Okuda, T; Tanaka, S; Taniwaki, M; Tsuda, S, 1989)
"A noncomparative pilot study was conducted to assess the potential usefulness of aztreonam in pulmonary exacerbations of cystic fibrosis."	3.67	Efficacy of aztreonam in pulmonary exacerbations of cystic fibrosis. ( Black, PG; Bosso, JA; Matsen, JM, 1987)
"Nineteen patients with hematological malignancies (5 malignant lymphomas, 9 acute leukemia and 5 other hematological diseases) were treated with aztreonam alone or in combination for infection."	3.67	Treatment of infections during hematologic malignancies with aztreonam, a new antibiotic. ( Invernizzi, R; Mazzone, A; Nastasi, G; Ricevuti, G; Rizzo, SC, 1986)
"Aztreonam (AZT) was evaluated for its clinical efficacy in a total of 10 cases, namely 3 cases of endometritis, 6 cases of intrapelvic infections, 1 case of puerperal pyelonephritis."	3.67	[Clinical evaluation of aztreonam in the field of obstetrics and gynecology]. ( Ijuin, H, 1985)
"Nineteen patients with community- or hospital-acquired gram-negative pneumonia were treated with aztreonam."	3.67	Aztreonam therapy for gram-negative pneumonia. ( Bollinger, M; Greenberg, RN; Luppen, KL; McMillian, R; Reilly, PM, 1985)
"Aztreonam therapy was evaluated for the management of 80 patients with gram-negative bacilli lower respiratory tract infections."	3.67	Efficacy and safety of aztreonam versus tobramycin for aerobic gram-negative bacilli lower respiratory tract infections. ( Ramirez-Ronda, CH; Rodriguez, JR, 1985)
"Aztreonam, a new monobactam antibiotic with specific gram-negative aerobic activity, was used in combination with clindamycin in the treatment of 40 women with pelvic infection, including post-partum endometritis, pelvic inflammatory disease, and post-hysterectomy pelvic cellulitis."	3.67	Aztreonam plus clindamycin as therapy for pelvic infections in women. ( Aldridge, KE; Cole, C; Crapanzano, JC; Pastorek, JG, 1985)
"One hundred and nine patients with infection accompanying hematologic disorders including leukemia and lymphoma were treated with aztreonam (AZT)."	3.67	[Therapeutic effectiveness of aztreonam on severe infections associated with hematologic disorders. Hanshin Infection Study Group]. ( Hirayama, F; Horiuchi, A; Kawagoe, H; Kitani, T; Masaoka, T; Nagai, K; Okamoto, Y; Shibata, H; Yasunaga, K; Yonezawa, T, 1985)
"Clinical usage of aztreonam (AZT), a newly synthesized antibiotic which belongs to monobactam, was evaluated for its efficacy and safety in 22 patients aged from 1 month-old to 13 year-5 month-old with bacterial infections and the following results were obtained."	3.67	[Clinical evaluation of aztreonam in children]. ( Ito, S; Mikawa, H; Mochizuki, Y; Ohkubo, H; Yoshida, A, 1985)
"The penetration of aztreonam (AZT), a new synthetic monobactam, into cerebrospinal fluid (CSF) and the clinical studies for bacterial infections were carried out."	3.67	[Clinical evaluation on aztreonam in pediatric field and fundamental study on its penetration into cerebrospinal fluid]. ( Furukawa, S; Okada, T, 1985)
" Pharmacokinetic parameters for each antibiotic were determined using population modeling, and variables potentially related to outcomes were evaluated using tree-based modeling, logistic regression, and nonlinear regression methods."	2.70	Pharmacokinetics and pharmacodynamics of aztreonam and tobramycin in hospitalized patients. ( Ballow, CH; Booker, BM; Forrest, A; Schentag, JJ; Smith, PF, 2001)
"Aztreonam was administered at a dosage of 2 g every 8 hours and gentamicin at 5 mg/kg for the first 24 hours and then adjusted by serum monitoring to a peak of 6 to 8 micrograms/mL and a trough of less than 2 micrograms/mL; all patients received 900 mg of clindamycin every 8 hours."	2.67	Superiority of aztreonam/clindamycin compared with gentamicin/clindamycin in patients with penetrating abdominal trauma. ( Boucher, BA; Charland, SL; Croce, MA; Fabian, TC; Hess, MM; Rodman, JH; Wilson, RS; Wilson, SE, 1994)
" Pharmacokinetic study (1) Upon one-shot intravenous injection of AZT 1 g before delivery, maternal serum concentration of AZT was 89."	2.67	[Pharmacokinetics and clinical evaluations on aztreonam in perinatal infections in obstetrics and gynecology. A study of aztreonam in the perinatal co-research group]. ( Haga, H; Hirayama, H; Inoue, R; Matsuda, S; Mizoguchi, H; Oh, K; Sengoku, K; Shimizu, T; Tori-i, Y; Yamazaki, T, 1990)
" An adequate standard dosage of aztreonam could be established as 3-4 g/day in compromised patients, and it should be combined with gram-positive coverage when used empirically."	2.66	A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients. ( Bosch-Perez, A; Rabinad, E, 1989)
"Gram-negative pneumonia is a frequent complication in hospitalized patients, particularly in those with diminished defenses."	2.66	Comparative study of aztreonam in gram-negative pneumonia versus a therapeutic regimen that includes an aminoglycoside. Spanish Study Group. ( Gobernado, M; Marco, V; Rabinad, E; Santos, M, 1989)
"Aztreonam was compared with aminoglycoside antibiotics (tobramycin and amikacin) in a randomized, prospective, clinical trial in serious infections caused by gram-negative bacilli (GNB)."	2.66	Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by gram-negative bacilli. ( DeMaria, A; McCabe, WR; Porat, R; Saunders, CA; Treadwell, TL, 1989)
"Carumonam is a new monobactam antibiotic with potent activity against gram-negative aerobes."	2.66	Carumonam versus ceftazidime for urinary tract infections. ( Cassano, K; Edelstein, H; McCabe, R; Oster, S, 1988)
" Dosage of aztreonam was 2 to 8 g per day administered intravenously or intramuscularly for five to 52 days."	2.66	Aztreonam in the treatment of serious orthopedic infections. ( Beskin, J; Beville, R; Haddad, RJ; Holmes, B; Mogabgab, WJ; Pollock, B; Pribyl, C; Salzer, R, 1985)
" Serum concentration of AZT in 10 pediatric cases were measured by dosing 10, 20 and 40 mg/kg by one-shot intravenous injection to 3, 4 and 3 cases, respectively."	2.66	[Basic and clinical trials of aztreonam in the field of pediatrics]. ( Fujimoto, T; Kawakami, A; Koga, T; Motohiro, T; Nishiyama, T; Sakata, Y; Shimada, Y; Tanaka, K; Tominaga, K; Tomita, N, 1985)
"Aztreonam is a synthetic monobactam antibiotic that has excellent activity against aerobic gram-negative bacilli."	2.38	Aztreonam. ( Clark, P, 1992)
"The treatment of bacterial infections in neutropenic cancer patients presents a serious challenge to physicians."	2.38	Aztreonam in the prevention and treatment of infection in neutropenic cancer patients. ( Bodey, GP; Elting, L; Rolston, KV, 1990)
" Excretion is largely dependent on renal mechanisms, so dosage can be adjusted in the presence of renal impairment."	2.38	Aztreonam activity, pharmacology, and clinical uses. ( Neu, HC, 1990)
"Aztreonam is a useful addition to the available antibiotics for treatment of gram-negative infections."	2.38	Aztreonam. ( Scheld, WM; Tunkel, AR, 1990)
" In the treatment of children with urinary tract infection as well as other types of infections, aztreonam therapy in a dosage of 30 mg/kg given every 6 to 8 hours was associated with satisfactory clinical and microbiologic cure rates."	2.38	Clinical experience with aztreonam. ( Stutman, HR, 1989)
"Aztreonam has proven to be effective, safe therapy for serious and life-threatening infections caused by multiresistant aerobic gram negative bacteria."	2.37	Aztreonam: the first monobactam. ( Neu, HC, 1988)
"12 L/h/kg), and terminal half-life is 1."	2.37	Clinical pharmacokinetics of aztreonam. ( Mattie, H, 1988)
" Dosage reductions of these drugs may be appropriate in certain situations."	2.37	Therapeutic considerations in using combinations of newer beta-lactam antibiotics. ( Barriere, SL, 1986)
" push administration on the pharmacodynamic exposures of meropenem, cefepime, and aztreonam were evaluated."	1.46	Effects of i.v. push administration on β-lactam pharmacodynamics. ( Burgner, K; Butterfield-Cowper, JM, 2017)
"Aztreonam is a safe, well-tolerated antibiotic with a good response in psychogeriatric patients."	1.28	Clinical use of aztreonam in a psychogeriatric population. ( Roelandts, F, 1992)
"Aztreonam was discontinued in both patients."	1.28	Toxic epidermal necrolysis possibly linked to aztreonam in bone marrow transplant patients. ( Bianco, JA; McDonald, BJ; Singer, JW, 1992)
"Clinical and pharmacokinetic studies on aztreonam (AZT) were performed in neonates."	1.28	[Clinical and pharmacokinetic studies on aztreonam in neonates]. ( Abe, T; Fujii, R; Hashira, S; Meguro, H; Tajima, T, 1990)
"Aztreonam (AZT) was studied for its pharmacokinetics, clinical effect and effect on intestinal bacterial flora in neonates, and the results obtained are summarized as follows: 1."	1.28	[Pharmacokinetic and clinical studies on aztreonam in neonates and premature infants]. ( Akita, H; Ishizuka, Y; Iwata, S; Oikawa, T; Saito, N; Sato, Y; Sunakawa, K, 1990)
" The most appropriate dosage and administration scheme of AZT against Gram-negative infections in neonates seems to be 40-60 mg/kg/day, b."	1.28	[Studies of aztreonam in neonates]. ( Matsumoto, K; Nakanishi, Y; Nakazawa, S; Narita, A; Niino, K; Sato, H; Suzuki, H, 1990)
" The mean half-life time was 3."	1.28	[Pharmacokinetic and clinical studies on aztreonam in neonates]. ( Nishimura, T; Tabuki, K, 1990)
" Average daily dosage of AZT 46."	1.28	[Pharmacokinetic and clinical evaluations of aztreonam monotherapy and aztreonam and ampicillin combination therapy in neonates and premature infants]. ( Aramaki, M; Kawakami, A; Koga, T; Motohiro, T; Oda, K; Sakata, Y; Shimada, Y; Tanaka, K; Tominaga, K; Tomita, S, 1990)
" Serum half-life was 3."	1.28	[Pharmacokinetics and clinical studies of aztreonam in neonates and premature infants]. ( Fukuda, M; Inoguchi, S; Tanaka, H; Tsuji, Y, 1990)
"Aztreonam (AZT) was administered to immature infants, neonates and infants for preclinical and clinical studies."	1.28	[Preclinical and clinical studies on aztreonam in pediatric surgery]. ( Kimura, K; Miyano, T; Shimomura, H, 1990)
" Efficacy rate of AZT in the clinical application to 12 cases of perinatal infections via 2-4 g/day drip infusion (total dosage 8-24 g) was 91."	1.28	[Clinical studies on aztreonam in perinatal use]. ( Chimura, T; Funayama, T; Matsuo, M; Morisaki, N, 1990)
"In addition, combined treatments of bacterial infections should allow for a reduction in dosages of antibiotics while at the same time, achieving increased efficacy."	1.28	Potentiation by nonspecific immunostimulation of the efficacy of antibiotics in the treatment of experimental bacterial infections. ( Bizzini, B; Fattal-German, M, 1989)
"Aztreonam was administered to 25 neonates (16 term, 9 premature) with clinically and bacteriologically proved gram-negative infections."	1.28	Successful response of severe neonatal gram-negative infection to treatment with aztreonam. ( Constantopoulos, A; Loupa, H; Papoulias, G; Thomaidou, L, 1989)
" Tolerance to the drug was good in both groups, and in no instance did side effects necessitate modification of the dosing regimen."	1.28	The clinical use of aztreonam. ( Car, V; Krznar, B; Schönwald, S; Schoss-Vidensek, Z, 1989)
"Aztreonam was well tolerated."	1.28	Efficacy and safety of low dose aztreonam in the treatment of moderate to severe gram-negative bacterial infections. ( Carbon, C; Clergeot, A; Rosset, MA; Steru, D, 1989)
" Using serum levels of the drug obtained in blood samples, pharmacokinetic parameters were calculated and a simulation curve of serum levels was drawn automatically using a micro-computer."	1.28	[Pharmacokinetic evaluations and analysis of aztreonam in children]. ( Kawasaki, H, 1989)
"The in vitro synergistic activity of aztreonam in combination with piperacillin, moxalactam, cefotaxime, cefoperazone, and amikacin was examined against multiply resistant isolates of the family Enterobacteriaceae and Pseudomonas aeruginosa."	1.27	In vitro activity of aztreonam in combination with newer beta-lactams and amikacin against multiply resistant gram-negative bacilli. ( Buesing, MA; Jorgensen, JH, 1984)
"Aztreonam was used for a year to treat 106 hospitalized patients with a total of 131 documented gram-negative infections."	1.27	Treatment of serious gram-negative infections with aztreonam. ( Bollinger, M; Darji, TB; Greenberg, RN; Luppen, KL; McMillian, R; Noorani, AA; Reilly, PM; Wolk, SM, 1984)
"Eighteen patients with hematological malignancies received aztreonam in one of two dosing regimens, 1 or 2 g every 8 h for a total of 7 to 9 days."	1.27	Effect of aztreonam on throat and stool flora of cancer patients. ( Bodey, GP; Jones, PG; Rosenbaum, B; Swabb, EA, 1984)
"Aztreonam was administered as a single therapy to 7 patients and in association with metronidazole (18) and/or penicillin G (14) to 22 patients; in fact, anaerobes were isolated in ten patients."	1.27	[Aztreonam treatment of severe infections caused by gram-negative aerobic bacilli]. ( Dupeyron, JP; Froehly, S; Jehl, F; Monteil, H; Peter, JD; Rosset, MA, 1988)
"Carumonam is a new N-sulfo-beta-lactam antibiotic active against aerobic Gram-negative bacteria."	1.27	Clinical efficacy of carumonam. ( Blakemore, PH; Drabu, YJ; Mehtar, S, 1988)
"Aztreonam was given i."	1.27	Aztreonam in the treatment of serious gram-negative infections in the elderly. ( Deger, F; Douchamps, J; Freschi, E; Herchuelz, A; Nève, P; Thys, JP, 1988)
" Based on our results a dosage adjustment schedule for renal impairment is suggested."	1.27	Pharmacokinetics of aztreonam in infected patients. ( Mattie, H; Matze-van der Lans, A, 1986)
"Aztreonam was used in the initial treatment of infection of the urinary tract (23 cases), respiratory tract (17 cases), skin and soft tissue (12 cases), abdominal cavity (three cases), endocarditis (two cases), septicemia (eight cases), and osteomyelitis (two cases)."	1.27	Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections. ( Chandrasekar, P; Kannangara, W; LeFrock, JL; Molavi, A; Rolston, KV; Smith, BR, 1987)
"Aztreonam (AZT) was administered to 10 patients with obstetric and gynecologic infections to evaluate its clinical effect."	1.27	[Clinical studies on aztreonam in various infections in obstetrics and gynecology]. ( Iijima, S; Kawagoe, A; Miyagawa, S; Ogasawara, K; Saito, M; Tsunoda, H; Usuki, S, 1985)
"Aztreonam (AZT) was studied for the transfer into the pelvic dead space exudate in 5 patients who received radical hysterectomy due to uterocervical cancer, and for the clinical efficacy in the treatment of 5 cases of obstetrical and gynecological infections."	1.27	[Fundamental and clinical studies on aztreonam in the field of obstetrics and gynecology]. ( Hayasaki, M; Ito, K; Matsunami, K; Noda, K, 1985)
"Aztreonam seems to be an effective single agent therapy for many bacterial infections."	1.27	Evaluation of aztreonam in the treatment of severe bacterial infections. ( Bouza, E; García de la Torre, M; Guerrero, A; Hellín, T; Martínez-Beltrán, J; Rodríguez-Créixems, M; Romero-Vivas, J, 1985)
"Aztreonam was the first compound to emerge that fulfilled the objectives of the program."	1.27	Aztreonam: the first monobactam. ( Bonner, DP; Sykes, RB, 1985)
"Carumonam was highly active in vitro against members of the family Enterobacteriaceae, Pseudomonas aeruginosa, and Haemophilus influenzae and weakly active against Streptococcus pneumoniae, but it was not active against Staphylococcus aureus."	1.27	In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic. ( Imada, A; Kondo, M; Kuno, M; Okonogi, K; Yukishige, K, 1985)
"Aztreonam is a novel antimicrobial agent belonging to the monobactam class of antibiotics."	1.27	Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa. ( Neu, HC; Scully, BE, 1985)
"Aztreonam was well tolerated."	1.27	Treatment of gram-negative infections with aztreonam. ( Lee, TJ; Simons, WJ, 1985)
"Aztreonam is a monocyclic beta-lactam antibiotic that inhibits aerobic gram-negative bacilli, including beta-lactamase-producing species."	1.27	Current state of infectious diseases--potential areas of directed therapy with aztreonam. ( Neu, HC, 1985)
"6 to 121 ml/min per 70 kg, and the half-life ranged from 1."	1.27	Pharmacokinetics of aztreonam in patients with gram-negative infections. ( Apicella, MA; Cafarell, RF; Janicke, DM; Jusko, WJ; Parker, SW, 1985)
"Aztreonam (AZT) was evaluated for its safety, clinical efficacy and pharmacokinetics in children."	1.27	[Clinical and pharmacokinetic evaluations of aztreonam in children]. ( Arimasu, O; Fujii, R; Hiruma, F; Meguro, H; Shiraishi, H; Sohda, H; Sugamata, K, 1985)
"AZT was administered to 10 patients with bacterial infections with 100% clinical efficacy and 62."	1.27	[Fundamental and clinical studies on aztreonam in pediatrics]. ( Akita, H; Ishizuka, Y; Iwata, S; Saito, N; Sato, Y; Sunakawa, K, 1985)
" The levels of AZT into the feces by the multiple dosage were 0-840 micrograms/g."	1.27	[Fundamental and clinical studies of aztreonam in the field of pediatric]. ( Chikaoka, H; Kamigaki, M; Koido, R; Matsumoto, K; Nakada, Y; Nakazawa, S; Narita, A; Sato, H; Suzuki, H, 1985)

Research

Studies (230)

Authors

Clinical Trials (2)

Trial Overview

Trial Outcomes

Duration of Hospital Stay After Cesarean Delivery

Timeframe	Studies, this research(%)	All Research%
pre-1990	150 (65.22)	18.7374
1990's	72 (31.30)	18.2507
2000's	2 (0.87)	29.6817
2010's	4 (1.74)	24.3611
2020's	2 (0.87)	2.80

Authors	Studies
Snydman, DR	1
McDermott, L	1
Richter, DC	1
Brenner, T	1
Brinkmann, A	1
Grabein, B	1
Hochreiter, M	1
Heininger, A	1
Störzinger, D	1
Briegel, J	1
Pletz, M	1
Weigand, MA	1
Lichtenstern, C	1
Gahane, AY	1
Singh, V	1
Kumar, A	1
Kumar Thakur, A	1
Butterfield-Cowper, JM	1
Burgner, K	1
Yamanaka, Y	1
Shimabukuro, A	1
Lipp, HP	1
Takeuchi, M	1
Tanizawa, A	1
Mayumi, M	1
Kanellakopoulou, K	1
Manta, M	1
Tsagaraki, C	1
Giamarellou, H	2
Puleo, S	1
Sammartino, R	1
Blandino, G	1
Tempera, G	1
Scilletta, B	1
Rodolico, G	1
Rigatti, P	1
Montorsi, F	1
Guazzoni, G	1
Broglia, L	1
Maffezzini, M	1
Di Girolamo, V	1
Francesca, F	1
Grasso, M	1
Consonni, P	1
Germiniani, R	1
Hortling, L	1
Sipilä, R	1
Stutman, HR	4
Welch, DF	1
Scribner, RK	1
Marks, MI	2
Buesing, MA	1
Jorgensen, JH	1
Galanakis, N	1
Douzinas, E	1
Petrikkos, G	1
El Messidi, M	1
Papoulias, G	2
Daikos, GK	1
Greenberg, RN	2
Reilly, PM	2
Luppen, KL	2
McMillian, R	2
Bollinger, M	2
Wolk, SM	1
Darji, TB	1
Noorani, AA	1
Jones, PG	2
Bodey, GP	5
Swabb, EA	2
Rosenbaum, B	1
Neu, HC	7
Sykes, RB	2
Bonner, DP	2
Bush, K	1
Georgopapadakou, NH	1
Janning, SW	1
Arora, V	1
Barboza, E	1
del Castillo, M	1
Yi, A	1
Gotuzzo, E	1
Igari, J	1
Fabian, TC	1
Hess, MM	1
Croce, MA	1
Wilson, RS	1
Wilson, SE	1
Charland, SL	1
Rodman, JH	1
Boucher, BA	1
de Groot, HG	1
Hustinx, PA	1
Lampe, AS	1
Oosterwijk, WM	1
Danziger, LH	1
Greenfield, RA	1
Rubenstein, EB	1
Rolston, K	1
Benjamin, RS	1
Loewy, J	1
Escalante, C	1
Manzullo, E	1
Hughes, P	1
Moreland, B	1
Fender, A	1
Kennedy, K	1
Watanabe, Y	2
Minami, S	1
Hayashi, T	1
Araki, H	1
Kitayama, R	1
Ochiai, H	1
Raad, II	1
Whimbey, EE	1
Rolston, KV	4
Abi-Said, D	1
Hachem, RY	1
Pandya, RG	1
Ghaddar, HM	1
Karl, CL	1
Fishman, A	1
Chowers, M	1
Altaras, M	1
Beyth, Y	1
Lang, R	1
Smith, PF	1
Ballow, CH	1
Booker, BM	1
Forrest, A	1
Schentag, JJ	2
Roelandts, F	1
Murase, T	1
Clark, P	1
Chimura, T	6
Ise, H	1
Misawa, H	1
DuPont, HL	1
Ericsson, CD	1
Mathewson, JJ	1
de la Cabada, FJ	1
Conrad, DA	1
Walters, FP	1
Neal, DE	1
Rege, AB	1
George, WJ	1
Ricci, MJ	1
Hellstrom, WJ	1
Johnson, JG	1
Hardin, TC	1
McDonald, BJ	1
Singer, JW	1
Bianco, JA	1
Darveau, RP	1
Blake, J	1
Seachord, CL	1
Cosand, WL	1
Cunningham, MD	1
Cassiano-Clough, L	1
Maloney, G	1
Adachi, N	1
Hashiyama, M	1
Matsuda, I	1
Melekos, MD	1
Skoutelis, A	1
Chryssanthopoulos, C	1
Bassaris, HP	1
Satou, S	1
Funayama, T	3
Oono, T	1
Sakai, Y	1
Morisaki, N	5
Kanasugi, H	1
Takahashi, H	1
Saitou, N	1
Miyata, R	1
Sander, J	1
Bosso, JA	3
Black, PG	2
Nishino, T	1
Obana, Y	1
Kuzui, H	1
Murakami, T	1
Bodey, G	1
Reuben, A	1
Elting, L	3
Kantarjian, H	1
Keating, M	1
Hagemeister, F	1
Koller, C	1
Velasquez, W	1
Papadopoulos, N	1
Kilpatrick, M	1
Girgis, N	1
Farid, Z	1
Bishay, E	1
Cheng, IK	1
Chan, CY	1
Wong, WT	1
Knockaert, DC	1
Dejaeger, E	1
Nestor, L	1
Verbist, L	1
Pelemans, W	1
Ariza, J	1
Xiol, X	1
Esteve, M	1
Fernández Bañeres, F	1
Liñares, J	1
Alonso, T	1
Gudiol, F	1
Mozzillo, N	1
Formato, A	1
Quarto, G	1
Ottaviano, A	1
Romano, A	1
Urabe, A	1
Takaku, F	1
Mizoguchi, H	4
Nomura, T	2
Aoki, N	1
Yamaguchi, H	1
Mutoh, Y	1
Miura, Y	1
Toyama, K	1
Hirashima, K	1
Hirotsu, T	1
Akatsuka, J	1
Hoshi, Y	1
Uchiyama, H	1
Fujisawa, K	1
Kobayashi, N	2
Ishidoya, N	1
Ohira, M	1
Takayama, J	1
Ishida, Y	1
Cho, N	2
Fukunaga, K	2
Kunii, K	2
Kobayashi, I	1
Rubin, M	1
Walsh, T	1
Butler, K	1
Lee, J	1
Lecciones, J	1
Weinberger, M	1
Roilides, E	1
Gress, J	1
Marshall, D	1
Pizzo, PA	1
Umaña, MA	1
Odio, CM	1
Castro, E	1
Salas, JL	1
McCracken, GH	2
Morris, DL	1
Wilson, SR	1
Pain, J	1
Edwardson, KF	1
Jones, J	1
Strachan, C	1
Slack, R	1
Iwai, N	2
Nakamura, H	4
Taneda, Y	2
Maki, T	1
Ozaki, T	1
Matsui, S	1
Tauchi, N	1
Ichikawa, T	1
Fuji, R	2
Hashira, S	3
Tajima, T	3
Meguro, H	5
Abe, T	4
Sakata, H	3
Kakehashi, H	3
Fujita, K	3
Murono, K	3
Kaeriyama, M	3
Matsuda, S	2
Oh, K	2
Hirayama, H	2
Shimizu, T	3
Sengoku, K	2
Haga, H	3
Inoue, R	2
Yamazaki, T	3
Tori-i, Y	1
Tunkel, AR	1
Scheld, WM	1
Saito, N	3
Nichols, RL	1
Shimazaki, C	1
Inaba, T	1
Murakami, S	1
Oku, N	1
Itoh, K	1
Ura, Y	1
Nakagawa, M	1
Fujita, N	1
Levin, S	1
Cook, JL	2
Oka, T	1
Yoshioka, H	1
Hiramoto, A	1
Mori, Y	1
Maruyama, S	1
Fujii, R	2
Azagami, S	1
Isohata, E	1
Oikawa, T	2
Osano, M	1
Shiro, H	1
Sunakawa, K	3
Ishizuka, Y	3
Akita, H	2
Iwata, S	2
Sato, Y	2
Toyonaga, Y	1
Sugita, M	1
Kawamura, K	1
Seo, K	1
Sato, H	3
Narita, A	3
Suzuki, H	3
Nakazawa, S	5
Matsumoto, K	4
Nakanishi, Y	2
Niino, K	1
Arai, S	1
Sono, R	1
Shibata, T	1
Sakurai, M	2
Ihara, T	2
Kamiya, H	2
Inamochi, H	1
Taki, N	1
Suzuki, M	1
Nishimura, T	2
Tabuki, K	2
Okura, K	2
Matsuda, T	1
Nigami, H	1
Yamakawa, M	1
Kuroki, S	2
Haruta, T	2
Kobayashi, Y	2
Motohiro, T	2
Oda, K	1
Aramaki, M	1
Kawakami, A	2
Tanaka, K	2
Koga, T	2
Shimada, Y	2
Tomita, S	1
Sakata, Y	2
Tominaga, K	2
Tanaka, H	1
Fukuda, M	1
Inoguchi, S	1
Tsuji, Y	1
Shimomura, H	1
Miyano, T	1
Kimura, K	1
Yura, J	1
Suzuki, T	1
Hashimoto, T	1
Nakamura, T	2
Shimizu, Y	1
Minami, M	1
Kamiya, Y	1
Narita, H	1
Tsuruga, N	1
Torii, Y	2
Sagawa, T	1
Saitou, S	1
Makinoda, S	2
Negishi, H	1
Ohkohchi, T	1
Hanatani, K	1
Satoh, H	1
Tanaka, T	2
Fujimoto, S	2
Matsuo, M	2
Ito, K	2
Hirose, R	1
Tamaya, T	1
Yamada, Y	2
Izumi, K	1
Yamamoto, T	2
Yasuda, J	2
Okada, H	2
Iwasaku, K	1
Sánchez, C	1
Garau, J	1
Natali, M	1
Tonini, G	1
Tufo, E	1
Leggio, M	1
Carassai, A	1
Lopez, M	1
Apice, G	1
Beneduce, G	1
Bruni, GS	1
D'Aprile, M	1
Perna, M	1
Silvestro, P	1
Villari, P	1
Pergola, M	1
Bizzini, B	1
Fattal-German, M	1
Chambers, ST	1
Hirayama, T	1
DiPiro, JT	1
Bowden, TA	1
Rabinad, E	3
Bosch-Perez, A	1
Birolini, D	1
Moraes, MF	1
de Souza, OS	1
Albertazzi, A	1
Bonadio, M	1
Fusaroli, M	1
Lotti, T	1
Miano, L	1
Salvia, G	1
Sasdelli, M	1
Villa, G	1
Zucchelli, P	1
Ventriglia, L	3
Martelli, A	2
Cortecchia, V	2
Rivera-Vazquez, CR	1
Ramirez-Ronda, CH	3
Rodriguez, JR	2
Saavedra, S	1
Marco, V	1
Gobernado, M	1
Santos, M	1
DeMaria, A	1
Treadwell, TL	1
Saunders, CA	1
Porat, R	1
McCabe, WR	1
Rice, LB	1
Eliopoulos, GM	1
Matsen, JM	2
Saxon, A	2
Constantopoulos, A	1
Thomaidou, L	1
Loupa, H	1
Feris, J	1
Moledina, N	1
Rodriguez, WJ	1
Khan, WN	1
Puig, J	1
Wiedermann, BL	1
Ahmad, S	1
Trujillo, H	1
Harry, N	1
Arango, A	1
Benítez, G	1
Restrepo, F	1
Mejía, GI	1
Castrillón, AL	1
Ayroza-Galvão, PA	1
Milstein-Kuschnaroff, TM	1
Mimica, IM	1
Maassen, S	1
Barbosa Júnior, SP	1
Cavalcante, NJ	1
Lorenco, R	1
Mimica, LM	1
Martino, MD	1
Schönwald, S	1
Schoss-Vidensek, Z	1
Car, V	1
Krznar, B	1
Clergeot, A	1
Steru, D	1
Rosset, MA	2
Carbon, C	1
Kawasaki, H	1
Tirone, F	1
Musca, G	1
Filomia, D	1
Vigna, L	1
Tsuda, S	1
Tanaka, S	2
Nakagawa, H	1
Nishigaki, H	1
Okuda, T	1
Horiike, S	1
Taniwaki, M	1
Misawa, S	1
Inazawa, J	1
Dratwa, M	1
Glupczynski, Y	1
Lameire, N	1

Trial	Phase	Enrollment	Study Type	Start Date	Status
Safety Comparison of Antibiotics Administered Via Intravenous Push Versus Intravenous Piggyback to Adult Patients in the Emergency Department[NCT03360617]		220 participants (Anticipated)	Interventional	2017-10-18	Recruiting
Treatment Utility of Postpartum Antibiotics in Chorioamnionitis[NCT01585129]	Phase 4	80 participants (Actual)	Interventional	2010-09-30	Terminated (stopped due to Futility in patient enrollment)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

This is the duration of hospital stay (in days) after their cesarean delivery. (NCT01585129)
Timeframe: Up to 7 Days

Number of Paricipants With Endometritis

Intervention	days (Mean)
Postpartum Antibiotics	4
No Postpartum Antibiotics	4

Endometritis is defined as uterine infection and is diagnosed by maternal temp > 38.0C on two occasions over a 4 hour period or any temp > 39.0C after delivery > 12 hours after delivery. Endometritis will be managed per currently accepted endometritis protocol - (Amp 2 gQ6, Gentamicin 5 mg/kg q24, Clindamycin 900 mg q8). (NCT01585129)
Timeframe: 7 days post-partum

Number of Participants With Infection-related Complications

Intervention	Participants (Count of Participants)
Postpartum Antibiotics	4
No Postpartum Antibiotics	3

Infection related complications will include common complications attributed to infections there are not the primary outcome (endometritis). This will include infections of the wound and pelvic abscesses. (NCT01585129)
Timeframe: 7 days post-partum

Article	Year
[Revival of selected well-tried antibiotics. Special features of the antiinfective agents penicillin G, fosfomycin, aztreonam and colistin]. Medizinische Monatsschrift fur Pharmazeuten, 2012, Volume: 35, Issue:10 Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Colistin; Fosfomycin; Humans; Kidney Disease	2012
Symposium on antimicrobial therapy. V. The carbapenems and monobactams. The Journal of the Oklahoma State Medical Association, 1993, Volume: 86, Issue:2 Topics: Aztreonam; Bacterial Infections; Cephalosporins; Humans; Imipenem; Microbial Sensitivity Tests	1993
Aztreonam. Obstetrics and gynecology clinics of North America, 1992, Volume: 19, Issue:3 Topics: Aztreonam; Bacterial Infections; Costs and Cost Analysis; Female; Genital Diseases, Female; Humans;	1992
Aminoglycosides, imipenem, and aztreonam. Clinics in podiatric medicine and surgery, 1992, Volume: 9, Issue:2 Topics: Aminoglycosides; Aztreonam; Bacterial Infections; Dose-Response Relationship, Drug; Drug Resistance,	1992
The use of aztreonam in pediatric patients: a review. Pharmacotherapy, 1991, Volume: 11, Issue:1 Topics: Adult; Aztreonam; Bacterial Infections; Gram-Negative Aerobic Bacteria; Humans; Infant, Newborn; Men	1991
The febrile neutropenic patient: newer options for empirical therapy. Haematology and blood transfusion, 1990, Volume: 33 Topics: Agranulocytosis; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Carbapenems; Cephalosporins	1990
Aztreonam in the prevention and treatment of infection in neutropenic cancer patients. The American journal of medicine, 1990, Mar-23, Volume: 88, Issue:3C Topics: Agranulocytosis; Aztreonam; Bacterial Infections; Drug Therapy, Combination; Gram-Negative Bacteria;	1990
Aztreonam activity, pharmacology, and clinical uses. The American journal of medicine, 1990, Mar-23, Volume: 88, Issue:3C Topics: Aztreonam; Bacteria; Bacterial Infections; Humans; Microbial Sensitivity Tests	1990
Aztreonam. Infection control and hospital epidemiology, 1990, Volume: 11, Issue:9 Topics: Aztreonam; Bacterial Infections; Gram-Negative Bacteria; Humans	1990
[Role of the new beta lactams in severe infections. Imipenem and aztreonam: indications and limitations]. Enfermedades infecciosas y microbiologia clinica, 1989, Volume: 7 Suppl 1 Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; Bacterial Infections; Drug Evaluation; Drug Resistance,	1989
Carbapenems, monobactams and quinolones. The New Zealand medical journal, 1989, Jan-25, Volume: 102, Issue:860 Topics: Aztreonam; Bacterial Infections; Humans; Imipenem; Quinolones	1989
A comparison of monobactam antibiotics in surgical infections. American journal of surgery, 1989, Volume: 157, Issue:6 Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Bacteria; Bacterial Infections; Humans; Postopera	1989
Imipenem and aztreonam: current role in antimicrobial therapy. Current clinical topics in infectious diseases, 1989, Volume: 10 Topics: Aztreonam; Bacteria; Bacterial Infections; Costs and Cost Analysis; Humans; Imipenem	1989
Clinical experience with aztreonam. The Pediatric infectious disease journal, 1989, Volume: 8, Issue:9 Suppl Topics: Aztreonam; Bacterial Infections; Cystic Fibrosis; Gram-Negative Bacteria; Humans; Pseudomonas Infect	1989
The use of aztreonam in the cystic fibrosis patient. The Pediatric infectious disease journal, 1989, Volume: 8, Issue:9 Suppl Topics: Aztreonam; Bacterial Infections; Cystic Fibrosis; Gram-Negative Bacteria; Humans; Pseudomonas Infect	1989
Aztreonam in the management of gram-negative infections in penicillin-allergic patients: a review. The Pediatric infectious disease journal, 1989, Volume: 8, Issue:9 Suppl Topics: Aztreonam; Bacterial Infections; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Gram-Negati	1989
[Aztreonam]. The Japanese journal of antibiotics, 1988, Volume: 41, Issue:4 Topics: Animals; Aztreonam; Bacteria; Bacterial Infections; Clinical Trials as Topic; Drug Resistance, Micro	1988
Ureidopenicillins, aztreonam, and thienamycin: efficacy as single-drug therapy of severe infections and potential as components of combined therapy. The Journal of antimicrobial chemotherapy, 1986, Volume: 17 Suppl A Topics: Aminoglycosides; Ampicillin; Azlocillin; Aztreonam; Bacteria; Bacterial Infections; Drug Synergism;	1986
Aztreonam: the first monobactam. The Medical clinics of North America, 1988, Volume: 72, Issue:3 Topics: Aztreonam; Bacterial Infections; Gram-Negative Bacteria; Humans; Respiratory Tract Infections; Sepsi	1988
Clinical pharmacokinetics of aztreonam. Clinical pharmacokinetics, 1988, Volume: 14, Issue:3 Topics: Aging; Aztreonam; Bacterial Infections; Drug Administration Routes; Humans; Kidney; Kidney Diseases;	1988
Role of aztreonam in lower respiratory tract infections. Urology, 1988, Volume: 31, Issue:6 Suppl Topics: Aztreonam; Bacterial Infections; Cross Infection; Drug Evaluation; Gram-Negative Bacteria; Humans; I	1988
Aztreonam: review of the clinical experience and potential uses in pediatrics. The Pediatric infectious disease journal, 1988, Volume: 7, Issue:5 Topics: Adolescent; Aztreonam; Bacterial Infections; Child; Child, Preschool; Cross Reactions; Cystic Fibros	1988
Aztreonam: the first monobactam antibiotic. The Pediatric infectious disease journal, 1987, Volume: 6, Issue:6 Topics: Adult; Aztreonam; Bacterial Infections; Child; Child, Preschool; Clinical Trials as Topic; Gram-Nega	1987
Aztreonam. Connecticut medicine, 1987, Volume: 51, Issue:9 Topics: Aztreonam; Bacterial Infections; Drug Interactions; Gram-Negative Aerobic Bacteria; Humans; Microbia	1987
Aztreonam: a narrow spectrum against gram-negative aerobes. Drug and therapeutics bulletin, 1987, Nov-02, Volume: 25, Issue:22 Topics: Aztreonam; Bacterial Infections; Drug Resistance, Microbial; Gram-Negative Aerobic Bacteria; Humans	1987
Pathophysiology and management of postcesarean endomyometritis. Obstetrics and gynecology, 1986, Volume: 67, Issue:2 Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cephalosporins; Cesarean Section; Cli	1986
Therapeutic considerations in using combinations of newer beta-lactam antibiotics. Clinical pharmacy, 1986, Volume: 5, Issue:1 Topics: Amdinocillin; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cephalosporins; Drug Synergism	1986
Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs, 1986, Volume: 31, Issue:2 Topics: Anti-Bacterial Agents; Aztreonam; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta	1986
New antibiotics: areas of appropriate use. The Journal of infectious diseases, 1987, Volume: 155, Issue:3 Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Infections; beta-Lactamase Inhibitors; Cephalosporins; C	1987
Aztreonam--an overview. Drug intelligence & clinical pharmacy, 1985, Volume: 19, Issue:3 Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; Bacterial Infections; Chemical Phenomena; Chemistry; Cli	1985

Article	Year
Piperacillin plus aztreonam for treatment of neutropenic fever. Pediatrics international : official journal of the Japan Pediatric Society, 2003, Volume: 45, Issue:3 Topics: Adolescent; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Child; Child, Preschool; Drug Th	2003
Clindamycin plus amikacin versus clindamycin plus aztreonam in established intraabdominal infections. Surgery, 1994, Volume: 116, Issue:1 Topics: Abdomen; Abscess; Adult; Amikacin; Appendicitis; Aztreonam; Bacterial Infections; Clindamycin; Drug	1994
Superiority of aztreonam/clindamycin compared with gentamicin/clindamycin in patients with penetrating abdominal trauma. American journal of surgery, 1994, Volume: 167, Issue:3 Topics: Abdominal Injuries; Adult; Aztreonam; Bacterial Infections; Blood Transfusion; Clindamycin; Colon; D	1994
Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections. The Journal of antimicrobial chemotherapy, 1993, Volume: 32, Issue:3 Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Aztreonam; Bacterial Infections; Cilastatin; Ci	1993
Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer, 1993, Jun-01, Volume: 71, Issue:11 Topics: Administration, Oral; Adolescent; Adult; Aged; Ambulatory Care; Aztreonam; Bacteremia; Bacterial Inf	1993
A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients. Cancer, 1996, Apr-01, Volume: 77, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacterial Infections;	1996
Pharmacokinetics and pharmacodynamics of aztreonam and tobramycin in hospitalized patients. Clinical therapeutics, 2001, Volume: 23, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Aztreonam; Bacterial Infect	2001
[Aztreonam or gentamicin combined with piperacillin as empiric antibiotic therapy during neutropenia of patients with hematologic diseases]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1992, Volume: 66, Issue:2 Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Aztreonam; Bacterial Infections; Cefamandole; Drug Therap	1992
Oral aztreonam, a poorly absorbed yet effective therapy for bacterial diarrhea in US travelers to Mexico. JAMA, 1992, Apr-08, Volume: 267, Issue:14 Topics: Administration, Oral; Adolescent; Adult; Aztreonam; Bacterial Infections; Diarrhea; Double-Blind Met	1992
rhG-CSF and aztreonam as prophylaxis against infection in neutropenic children. Lancet (London, England), 1991, May-11, Volume: 337, Issue:8750 Topics: Aztreonam; Bacterial Infections; Child; Drug Evaluation; Female; Granulocyte Colony-Stimulating Fact	1991
A comparative study on aztreonam, ceftazidime and amikacin in the treatment of complicated urinary tract infections. Journal of chemotherapy (Florence, Italy), 1991, Volume: 3, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Aztreonam; Bacterial Infections; Ceftazidime; Female; Huma	1991
[Clinical effect of the combined use of aztreonam, amikacin and clindamycin in infectious disease in obstetrics and gynecology]. The Japanese journal of antibiotics, 1991, Volume: 44, Issue:3 Topics: Adult; Aged; Amikacin; Aztreonam; Bacterial Infections; Clindamycin; Drug Therapy, Combination; Fema	1991
Comparison of two schedules of cefoperazone plus aztreonam in the treatment of neutropenic patients with fever. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1991, Volume: 10, Issue:7 Topics: Aztreonam; Bacterial Infections; Cefoperazone; Drug Administration Schedule; Drug Therapy, Combinati	1991
A randomised prospective comparison of oral ofloxacin and intraperitoneal vancomycin plus aztreonam in the treatment of bacterial peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD). Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 1991, Volume: 11, Issue:1 Topics: Administration, Oral; Aztreonam; Bacterial Infections; Drug Therapy, Combination; Humans; Ofloxacin;	1991
Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients. Hepatology (Baltimore, Md.), 1991, Volume: 14, Issue:1 Topics: Adult; Aged; Ascitic Fluid; Aztreonam; Bacterial Infections; Cefotaxime; Female; Gram-Negative Bacte	1991
To assess the efficacy of prophylaxis in digestive tract surgery using a predictive model of complication risk. Hepato-gastroenterology, 1990, Volume: 37 Suppl 2 Topics: Aztreonam; Bacterial Infections; Chi-Square Distribution; Digestive System Diseases; Double-Blind Me	1990
[Clinical evaluation of aztreonam for infections accompanying febrile neutropenic children with hematologic disorders and solid tumors. A cooperative study]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:12 Topics: Adolescent; Age Factors; Aztreonam; Bacterial Infections; Cefmetazole; Child; Child, Preschool; Drug	1990
Evaluation of aztreonam and ampicillin vs. amikacin and ampicillin for treatment of neonatal bacterial infections. The Pediatric infectious disease journal, 1990, Volume: 9, Issue:3 Topics: Amikacin; Ampicillin; Aztreonam; Bacterial Infections; Drug Evaluation; Drug Therapy, Combination; F	1990
A comparison of aztreonam/metronidazole and cefotaxime/metronidazole in elective colorectal surgery: antimicrobial prophylaxis must include gram-positive cover. The Journal of antimicrobial chemotherapy, 1990, Volume: 25, Issue:4 Topics: Aztreonam; Bacterial Infections; Cefotaxime; Colon; Drug Therapy, Combination; Gram-Positive Bacteri	1990
[Pharmacokinetics and clinical studies on aztreonam in neonates and premature infants (the first report). Study on effectiveness and safety in mono-therapy with aztreonam. A study of aztreonam in the Perinatal Co-research Group]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:3 Topics: Age Factors; Aztreonam; Bacterial Infections; Birth Weight; Clinical Trials as Topic; Female; Half-L	1990
[Pharmacokinetics and clinical studies on aztreonam in neonates and premature infants (the second report). Study on effectiveness and safety in combination therapy using aztreonam and ampicillin. A study of aztreonam in the Perinatal Co-research Group]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:3 Topics: Ampicillin; Aztreonam; Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Fe	1990
[Pharmacokinetics and clinical evaluations on aztreonam in perinatal infections in obstetrics and gynecology. A study of aztreonam in the perinatal co-research group]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:4 Topics: Adult; Amniotic Fluid; Aztreonam; Bacterial Infections; Clinical Trials as Topic; Female; Fetal Bloo	1990
A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients. Chemotherapy, 1989, Volume: 35 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Bacterial Infecti	1989
Comparison of aztreonam plus clindamycin with tobramycin plus clindamycin in the treatment of intra-abdominal infections. Chemotherapy, 1989, Volume: 35 Suppl 1 Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Aztreonam; Bacterial Infections; Clindamycin; C	1989
Multicenter comparative study of aztreonam and gentamicin in the treatment of renal and urinary tract infections. Chemotherapy, 1989, Volume: 35 Suppl 1 Topics: Adult; Aged; Ambulatory Care; Aztreonam; Bacterial Infections; Female; Gentamicins; Humans; Injectio	1989
Aztreonam in the treatment of urinary tract infections: a multicenter trial. Chemotherapy, 1989, Volume: 35 Suppl 1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aztreonam; Bacterial Infections; Child; Cross Infection;	1989
A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections. Chemotherapy, 1989, Volume: 35 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Aztreonam; Bacterial Infections; Clindamycin; Clinical Tri	1989
Comparative study of aztreonam in gram-negative pneumonia versus a therapeutic regimen that includes an aminoglycoside. Spanish Study Group. Chemotherapy, 1989, Volume: 35 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Bacterial Infecti	1989
Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by gram-negative bacilli. Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:8 Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Double-Blind M	1989
Aztreonam in CAPD peritonitis. Lancet (London, England), 1987, Jul-25, Volume: 2, Issue:8552 Topics: Aztreonam; Bacterial Infections; Clinical Trials as Topic; Gram-Negative Bacteria; Humans; Peritonea	1987
[An Italian multicenter study on the efficacy and tolerability of aztreonam in the treatment of urinary tract infections]. La Clinica terapeutica, 1988, May-15, Volume: 125, Issue:3 Topics: Adolescent; Adult; Aged; Aztreonam; Bacterial Infections; Child; Drug Tolerance; Female; Humans; Mal	1988
[Aztreonam]. The Japanese journal of antibiotics, 1988, Volume: 41, Issue:4 Topics: Animals; Aztreonam; Bacteria; Bacterial Infections; Clinical Trials as Topic; Drug Resistance, Micro	1988
Carumonam versus ceftazidime for urinary tract infections. Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:7 Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Ceftazidime; Drug Tolerance; Female;	1988
[Clinical efficacy of aztreonam in patients with complicated urinary tract infections]. Hinyokika kiyo. Acta urologica Japonica, 1988, Volume: 34, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Aztreonam; Bacterial Infections; Che	1988
The use of aztreonam in serious gram-negative infections. The Journal of antimicrobial chemotherapy, 1988, Volume: 21, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aztreonam; Bacterial Infections; Clinical Trials as Topi	1988
Aztreonam: the first monobactam antibiotic. The Pediatric infectious disease journal, 1987, Volume: 6, Issue:6 Topics: Adult; Aztreonam; Bacterial Infections; Child; Child, Preschool; Clinical Trials as Topic; Gram-Nega	1987
Amikacin plus ceftazidime versus amikacin plus piperacillin versus amikacin plus aztreonam in infections in neoplastic patients with granulocytopenia. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:6 Topics: Adult; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Ceftazidim	1987
Aztreonam plus cefazolin: a double beta-lactam combination as empirical therapy in febrile cancer patients with or without granulocytopenia. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl Topics: Agranulocytosis; Aztreonam; Bacterial Infections; Cefazolin; Ceftriaxone; Clinical Trials as Topic;	1987
Pathophysiology and management of postcesarean endomyometritis. Obstetrics and gynecology, 1986, Volume: 67, Issue:2 Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cephalosporins; Cesarean Section; Cli	1986
Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs, 1986, Volume: 31, Issue:2 Topics: Anti-Bacterial Agents; Aztreonam; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta	1986
Aztreonam: worldwide clinical experience with the first monobactam. New Jersey medicine : the journal of the Medical Society of New Jersey, 1986, Volume: Spec No Topics: Aztreonam; Bacterial Infections; beta-Lactamases; Clinical Trials as Topic; Drug Resistance, Microbi	1986
Aztreonam: early clinical studies in New Jersey. New Jersey medicine : the journal of the Medical Society of New Jersey, 1986, Volume: Spec No Topics: Aged; Aztreonam; Bacterial Infections; Cefamandole; Clinical Trials as Topic; Drug Resistance, Micro	1986
Aztreonam therapy in neutropenic patients with cancer. The American journal of medicine, 1986, Volume: 81, Issue:2 Topics: Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Aztreonam;	1986
Aztreonam (Azactam). The Medical letter on drugs and therapeutics, 1987, May-08, Volume: 29, Issue:739 Topics: Aztreonam; Bacterial Infections; Biological Availability; Clinical Trials as Topic; Drug Administrat	1987
Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia. The American journal of medicine, 1985, Feb-08, Volume: 78, Issue:2A Topics: Aged; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Clinical Trials as Topic; Critical Car	1985
Aztreonam in the treatment of serious orthopedic infections. The American journal of medicine, 1985, Feb-08, Volume: 78, Issue:2A Topics: Adult; Aged; Anti-Bacterial Agents; Arthritis, Infectious; Aztreonam; Bacterial Infections; Clinical	1985
Aztreonam: worldwide overview of the treatment of patients with gram-negative infections. The American journal of medicine, 1985, Feb-08, Volume: 78, Issue:2A Topics: Abdomen; Adult; Anti-Bacterial Agents; Arthritis, Infectious; Aztreonam; Bacterial Infections; Clini	1985
Aztreonam--an overview. Drug intelligence & clinical pharmacy, 1985, Volume: 19, Issue:3 Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; Bacterial Infections; Chemical Phenomena; Chemistry; Cli	1985
[Bacteriological, pharmacokinetic and clinical studies on aztreonam in the pediatric field. Pediatric Study Group of Aztreonam]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:11 Topics: Age Factors; Aztreonam; Bacteria; Bacterial Infections; Child; Child, Preschool; Clinical Trials as	1985
[Basic and clinical trials of aztreonam in the field of pediatrics]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:11 Topics: Adolescent; Age Factors; Aztreonam; Bacterial Infections; Child; Clinical Trials as Topic; Drug Eval	1985

Article	Year
Microbiology spectrum, 2021, 12-22, Volume: 9, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacteria, Anaerobic; Bacterial Infections; D	2021
[New antibiotics for severe infections due to multidrug-resistant pathogens : Definitive treatment and escalation]. Der Anaesthesist, 2019, Volume: 68, Issue:11 Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Colistin; Drug Resistance, Multiple, Bacteri	2019
Development of mechanism-based antibacterial synergy between Fmoc-phenylalanine hydrogel and aztreonam. Biomaterials science, 2020, Mar-31, Volume: 8, Issue:7 Topics: Animals; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Bacterial Load; Dipeptides; Disease	2020
Effects of i.v. push administration on β-lactam pharmacodynamics. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2017, May-01, Volume: 74, Issue:9 Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cefepime; Drug Administration Schedule; Heal	2017
Septic abortion presenting as a right lower trapezius abscess secondary to Bacteroides fragilis bacteraemia. BMJ case reports, 2017, Aug-21, Volume: 2017 Topics: Abortion, Septic; Abscess; Adult; Ampicillin; Anti-Bacterial Agents; Aztreonam; Bacteremia; Bacteria	2017
In vitro and in vivo experience with carumonam: a preliminary report. Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacteria; Bacterial Infections; Clinical Trials as Topic; F	1989
Colorectal surgery: short-term prophylaxis with aztreonam plus clindamycin versus gentamicin plus clindamycin. Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl Topics: Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Aztreonam; Bacterial Infections; Clindamycin	1989
Antibiotic prophylaxis with aztreonam in patients with kidney stone disease submitted to extracorporeal shock wave lithotripsy. Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Aztreonam; Bacteremia; Bacterial Infections; Kidney C	1989
Multiresistant Serratia marcescens peritonitis in a patient on continuous ambulatory peritoneal dialysis (CAPD) successfully treated with Azthreonam (S26,776) a new monobactam antibiotic. Clinical nephrology, 1984, Volume: 21, Issue:6 Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Drug Resistance, Microbial; Humans; M	1984
In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patients. Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:2 Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; Bacterial Infections; Cefoxitin; Child; Drug Synergism;	1984
In vitro activity of aztreonam in combination with newer beta-lactams and amikacin against multiply resistant gram-negative bacilli. Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:2 Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Drug Resistance, Microbial; Drug S	1984
Evaluation of aztreonam in difficult-to-treat infections with prolonged posttreatment follow-up. Antimicrobial agents and chemotherapy, 1984, Volume: 26, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Drug Resistance, Microbial; Fem	1984
Treatment of serious gram-negative infections with aztreonam. The Journal of infectious diseases, 1984, Volume: 150, Issue:5 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Drug Evaluation; En	1984
Effect of aztreonam on throat and stool flora of cancer patients. Antimicrobial agents and chemotherapy, 1984, Volume: 26, Issue:6 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Aztreonam; Bacteria, Aerobic; Bacteria, Anaerobic; B	1984
Trends in the development of beta-lactam antibiotics. Scandinavian journal of infectious diseases. Supplementum, 1984, Volume: 42 Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cephalosporins; Humans; Imipenem; Penicillin	1984
Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria. Antimicrobial agents and chemotherapy, 1982, Volume: 21, Issue:1 Topics: Animals; Anti-Bacterial Agents; Aztreonam; Bacteria; Bacterial Infections; Bacterial Proteins; beta-	1982
More on prophylaxis with aztreonam plus metronidazole during appendectomy. American journal of hospital pharmacy, 1994, Sep-01, Volume: 51, Issue:17 Topics: Appendectomy; Aztreonam; Bacterial Infections; Drug Therapy, Combination; Humans; Metronidazole; Sur	1994
[Reevaluation of current antimicrobials. Series 15: aztreonam. Discussion]. The Japanese journal of antibiotics, 1994, Volume: 47, Issue:9 Topics: Aztreonam; Bacteria; Bacterial Infections; Clindamycin; Drug Resistance, Microbial; Drug Therapy, Co	1994
[Antibacterial activity of aztreonam against clinical isolates]. The Japanese journal of antibiotics, 1994, Volume: 47, Issue:5 Topics: Aztreonam; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Humans; Multicenter Studies a	1994
Prophylaxis with aztreonam plus metronidazole during appendectomy. American journal of hospital pharmacy, 1993, Volume: 50, Issue:11 Topics: Appendectomy; Aztreonam; Bacterial Infections; Humans; Metronidazole; Surgical Wound Infection	1993
In vitro antibacterial properties of T-5575 and T-5578 novel parenteral 2-carboxypenams. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:12 Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamase	1995
Aztreonam plus piperacillin--empiric treatment of neutropenic fever in gynecology-oncology patients receiving cisplatin-based chemotherapy. European journal of gynaecological oncology, 1998, Volume: 19, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Aztreonam; Bacterial	1998
Clinical use of aztreonam in a psychogeriatric population. Acta clinica Belgica, 1992, Volume: 47, Issue:4 Topics: Aged; Aztreonam; Bacterial Infections; Dementia; Drug Therapy, Combination; Female; Floxacillin; Hum	1992
New diarrhea treatment coming? The Journal of the Oklahoma State Medical Association, 1992, Volume: 85, Issue:5 Topics: Administration, Oral; Adult; Aztreonam; Bacterial Infections; Child; Diarrhea; Female; Humans; Pregn	1992
[In vitro study on efficacy of combination use of aspoxicillin and beta-lactam preparations (ceftazidime, cefmetazole and aztreonam) against bacteria isolated from abdominal infections]. The Japanese journal of antibiotics, 1992, Volume: 45, Issue:7 Topics: Amoxicillin; Anti-Bacterial Agents; Aztreonam; Bacteria; Bacterial Infections; beta-Lactamases; Bili	1992
Cavernous tissue antibiotic levels in penile prosthesis surgery. The Journal of urology, 1992, Volume: 147, Issue:5 Topics: Aztreonam; Bacterial Infections; Gentamicins; Humans; Male; Penile Prosthesis; Penis; Prosthesis-Rel	1992
Toxic epidermal necrolysis possibly linked to aztreonam in bone marrow transplant patients. The Annals of pharmacotherapy, 1992, Volume: 26, Issue:1 Topics: Adult; Aztreonam; Bacterial Infections; Bone Marrow Transplantation; Graft vs Host Disease; Humans;	1992
Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity. The Journal of clinical investigation, 1992, Volume: 90, Issue:2 Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cefepime; Ceph	1992
[Aztreonam. A small-spectrum antibiotic in gram-negative infections]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1991, Aug-10, Volume: 111, Issue:18 Topics: Aztreonam; Bacterial Infections; Gram-Negative Aerobic Bacteria; Gram-Negative Anaerobic Bacteria; H	1991
[Combination antibacterial effects between aztreonam and eight other antibiotics]. The Japanese journal of antibiotics, 1991, Volume: 44, Issue:1 Topics: Amoxicillin; Animals; Aztreonam; Bacterial Infections; Drug Resistance, Microbial; Drug Synergism; D	1991
Aztreonam for treating meningitis caused by gram-negative rods. Scandinavian journal of infectious diseases, 1991, Volume: 23, Issue:1 Topics: Adult; Aztreonam; Bacterial Infections; Child; Child, Preschool; Female; Gram-Negative Bacteria; Hum	1991
Aztreonam-flucloxacillin double beta-lactam treatment as empirical therapy of serious infections in very elderly patients. Age and ageing, 1991, Volume: 20, Issue:2 Topics: Aged; Aged, 80 and over; Aztreonam; Bacterial Infections; Drug Evaluation; Drug Therapy, Combination	1991
[Combination therapy with aztreonam and clindamycin on severe infections accompanying neutropenic patients with hematological disorders]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:10 Topics: Adult; Aged; Aztreonam; Bacterial Infections; Clindamycin; Drug Evaluation; Drug Therapy, Combinatio	1990
[Studies on aztreonam in the perinatal period]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:4 Topics: Adult; Amniotic Fluid; Aztreonam; Bacterial Infections; Drug Evaluation; Drug Resistance, Microbial;	1990
[Pharmacokinetic, bacteriological and clinical studies on aztreonam in neonates]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:3 Topics: Ampicillin; Aztreonam; Bacterial Infections; Drug Evaluation; Drug Resistance, Microbial; Drug Thera	1990
[Influences of postoperative prophylaxis treatments on vaginal bacteria flora at hysterectomy]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:7 Topics: Adult; Aztreonam; Bacteria; Bacterial Infections; Colony Count, Microbial; Female; Humans; Hysterect	1990
Surgery-related infections: a challenge for the physician. Introduction. Surgery, gynecology & obstetrics, 1990, Volume: 171 Suppl Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cross Infection; Drug Resis	1990
[Effect of combination therapy with carumonam and clindamycin on severe infections in patients with hematologic malignancies]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:8 Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Clindamycin; Drug Evaluation; D	1990
Aztreonam's role in the treatment of gram-negative infections. Proceedings of a symposium. March 15, 1989, New York, New York. The American journal of medicine, 1990, Mar-23, Volume: 88, Issue:3C Topics: Aztreonam; Bacterial Infections; Gram-Negative Bacteria; Humans	1990
Empiric antibiotic use--aztreonam as a model. The American journal of medicine, 1990, Mar-23, Volume: 88, Issue:3C Topics: Aztreonam; Bacterial Infections; Drug Therapy, Combination; Humans	1990
Gram-negative bacillary pneumonia in the nosocomial setting. Role of aztreonam therapy. The American journal of medicine, 1990, Mar-23, Volume: 88, Issue:3C Topics: Aztreonam; Bacterial Infections; Cross Infection; Gram-Negative Bacteria; Humans; Microbial Sensitiv	1990
[Clinical and pharmacokinetic evaluation of aztreonam in neonates]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:3 Topics: Ampicillin; Aztreonam; Bacterial Infections; Drug Evaluation; Drug Therapy, Combination; Female; Hum	1990
[Clinical and pharmacokinetic studies on aztreonam in neonates]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:3 Topics: Ampicillin; Aztreonam; Bacteria; Bacterial Infections; Drug Evaluation; Drug Resistance, Microbial;	1990
[Pharmacokinetics and clinical safety of aztreonam in neonates]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:3 Topics: Age Factors; Aztreonam; Bacterial Infections; Female; Humans; Infant, Newborn; Male	1990
[Pharmacokinetic and clinical studies on aztreonam in neonates and premature infants]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:3 Topics: Ampicillin; Aztreonam; Bacterial Infections; Drug Evaluation; Drug Therapy, Combination; Female; Hum	1990
[Pharmacokinetic and clinical evaluation of aztreonam in neonates and premature infants]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:3 Topics: Ampicillin; Aztreonam; Bacterial Infections; Drug Evaluation; Drug Therapy, Combination; Female; Hum	1990
[Studies of aztreonam in neonates]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:3 Topics: Aztreonam; Bacterial Infections; Female; Half-Life; Humans; Infant, Newborn; Infusions, Intravenous;	1990
[Pharmacokinetics and clinical studies on aztreonam in neonates]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:3 Topics: Aztreonam; Bacterial Infections; Drug Evaluation; Female; Humans; Infant, Newborn; Infusions, Intrav	1990
[Pharmacokinetic and clinical studies on aztreonam in neonates]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:3 Topics: Ampicillin; Aztreonam; Bacterial Infections; Drug Therapy, Combination; Female; Half-Life; Humans; I	1990
[Clinical evaluation of aztreonam in neonatal infections]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:3 Topics: Ampicillin; Aztreonam; Bacterial Infections; Drug Evaluation; Drug Therapy, Combination; Female; Hum	1990
[Pharmacokinetic and clinical evaluations of aztreonam monotherapy and aztreonam and ampicillin combination therapy in neonates and premature infants]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:3 Topics: Ampicillin; Aztreonam; Bacterial Infections; Drug Evaluation; Drug Therapy, Combination; Female; Hum	1990
[Pharmacokinetics and clinical studies of aztreonam in neonates and premature infants]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:3 Topics: Ampicillin; Aztreonam; Bacterial Infections; Drug Evaluation; Drug Therapy, Combination; Female; Hal	1990
[Preclinical and clinical studies on aztreonam in pediatric surgery]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:3 Topics: Aztreonam; Bacterial Infections; Bile; Biliary Atresia; Female; Humans; Infant, Newborn; Infant, Pre	1990
[Pharmacokinetics and clinical evaluation of aztreonam in pediatric surgery]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:3 Topics: Aztreonam; Bacterial Infections; Bile; Biliary Atresia; Cholangitis; Female; Humans; Infant, Newborn	1990
[Pharmacokinetic and clinical studies on aztreonam in perinatal period]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:4 Topics: Adult; Amniotic Fluid; Aztreonam; Bacterial Infections; Chorioamnionitis; Female; Fetal Blood; Genit	1990
[Basic and clinical studies on aztreonam in obstetric and gynecologic infections during the perinatal period]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:4 Topics: Adult; Amniotic Fluid; Aztreonam; Bacterial Infections; Female; Fetal Blood; Gram-Negative Bacteria;	1990
[Clinical studies on aztreonam in perinatal use]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:4 Topics: Adult; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Humans; Infusions, Intravenous; Pre	1990
[Transplacental transfer and clinical application of aztreonam]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:4 Topics: Adult; Amniotic Fluid; Aztreonam; Bacterial Infections; Female; Fetal Blood; Humans; Infusions, Intr	1990
[Pharmacokinetic and clinical studies on aztreonam in the perinatal period]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:4 Topics: Adult; Amniotic Fluid; Aztreonam; Bacterial Infections; Female; Fetal Blood; Humans; Infusions, Intr	1990
[Pharmacokinetic and clinical studies on aztreonam in the perinatal period in obstetrics and gynecology]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:4 Topics: Adult; Amniotic Fluid; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Fetal Blood; Humans	1990
[Aztreonam and oxacillin in the treatment of febrile neutropenic patients with solid tumors]. La Clinica terapeutica, 1989, Sep-15, Volume: 130, Issue:5 Topics: Adult; Aged; Agranulocytosis; Aztreonam; Bacterial Infections; Female; Fever; Humans; Male; Middle A	1989
[Bacterial infections in cancer patients without neutropenia. Comparison between 2 antibiotic combinations (aztreonam and oxacillin versus cefoxitin and tobramycin)]. La Clinica terapeutica, 1989, Nov-15, Volume: 131, Issue:3 Topics: Adult; Aged; Aztreonam; Bacterial Infections; Cefoxitin; Drug Evaluation; Drug Therapy, Combination;	1989
Potentiation by nonspecific immunostimulation of the efficacy of antibiotics in the treatment of experimental bacterial infections. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1989, Volume: 43, Issue:10 Topics: Adjuvants, Immunologic; Ampicillin; Animals; Anti-Bacterial Agents; Aztreonam; Bacterial Infections;	1989
[Clinical effects of cefodizime against infectious diseases in obstetrics and gynecology]. The Japanese journal of antibiotics, 1989, Volume: 42, Issue:10 Topics: Adolescent; Adult; Aged; Aztreonam; Bacteria; Bacterial Infections; Cefotaxime; Clindamycin; Drug Ev	1989
Aztreonam: new developments and current perspectives. Papers presented at the International Congress for Infectious Diseases. Rio de Janeiro, 1988. Chemotherapy, 1989, Volume: 35 Suppl 1 Topics: Aztreonam; Bacterial Infections; Humans	1989
Successful response of severe neonatal gram-negative infection to treatment with aztreonam. Chemotherapy, 1989, Volume: 35 Suppl 1 Topics: Aztreonam; Bacterial Infections; Gram-Negative Bacteria; Humans; Infant, Newborn; Infant, Premature,	1989
Aztreonam in the treatment of gram-negative meningitis and other gram-negative infections. Chemotherapy, 1989, Volume: 35 Suppl 1 Topics: Aztreonam; Bacterial Infections; Child; Child, Preschool; Female; Gastroenteritis; Gram-Negative Bac	1989
Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients. Chemotherapy, 1989, Volume: 35 Suppl 1 Topics: Abscess; Aerobiosis; Appendix; Aztreonam; Bacterial Infections; Cecal Diseases; Child, Preschool; Fe	1989
Aztreonam in the treatment of bacterial meningitis. Chemotherapy, 1989, Volume: 35 Suppl 1 Topics: Aztreonam; Bacterial Infections; Child, Preschool; Female; Humans; Infant; Male; Meningitis; Meningi	1989
The clinical use of aztreonam. Chemotherapy, 1989, Volume: 35 Suppl 1 Topics: Adult; Aged; Aztreonam; Bacterial Infections; Female; Humans; Male; Middle Aged; Respiratory Tract I	1989
Efficacy and safety of low dose aztreonam in the treatment of moderate to severe gram-negative bacterial infections. The Journal of antimicrobial chemotherapy, 1989, Volume: 23, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aztreonam; Bacterial Infections; Female; Gram-Negative B	1989
[Pharmacokinetic evaluations and analysis of aztreonam in children]. The Japanese journal of antibiotics, 1989, Volume: 42, Issue:6 Topics: Adolescent; Age Factors; Aztreonam; Bacterial Infections; Child; Child, Preschool; Female; Half-Life	1989
[Evaluation of the therapeutic efficacy of aztreonam in the treatment of infection caused by sensitive microorganisms]. Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques, 1989, Volume: 11, Issue:1 Topics: Aztreonam; Bacteria; Bacterial Infections; Humans; Microbial Sensitivity Tests	1989
[Clinical evaluation of a combination therapy with aztreonam and clindamycin for severe infections in leukemia and related disorders]. The Japanese journal of antibiotics, 1989, Volume: 42, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Aztreonam; Bacterial Infections; Clindamycin; Drug Evaluation; Drug	1989
Aztreonam: new developments in the treatment of gram-negative infections in children. Chicago, Illinois, November 17, 1988. Proceedings. The Pediatric infectious disease journal, 1989, Volume: 8, Issue:9 Suppl Topics: Aztreonam; Bacterial Infections; Child; Gram-Negative Bacteria; Humans	1989
[Use of aztreonam in the treatment of acute and flare-ups of chronic infectious bronchopneumopathies]. La Clinica terapeutica, 1988, Jan-31, Volume: 124, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Aztreonam; Bacterial Infections; Bronchial Diseases; Bronchopneumoni	1988
[Aztreonam treatment of severe infections caused by gram-negative aerobic bacilli]. Pathologie-biologie, 1988, Volume: 36, Issue:5 Topics: Aged; Aged, 80 and over; Aztreonam; Bacterial Infections; Cross Infection; Drug Evaluation; Female;	1988
[Susceptibility of clinically isolated strains to aztreonam]. The Japanese journal of antibiotics, 1988, Volume: 41, Issue:11 Topics: Aztreonam; Bacterial Infections; Cephalosporins; Enterobacteriaceae; Humans; Microbial Sensitivity T	1988
[Third generation cephalosporins, monobactams and carbapenems]. La Revue du praticien, 1988, Mar-10, Volume: 38, Issue:8 Topics: Aztreonam; Bacteria; Bacterial Infections; Cefotaxime; Cephalosporins; Imipenem; Thienamycins	1988
[Efficacy of the piperacillin-aztreonam combination in antibiotic prophylaxis during the neonatal period]. Minerva pediatrica, 1988, Volume: 40, Issue:7 Topics: Aztreonam; Bacterial Infections; Drug Evaluation; Drug Therapy, Combination; Drug Tolerance; Gestati	1988
[Antibacterial activities of monobactams against fresh clinical isolates]. The Japanese journal of antibiotics, 1988, Volume: 41, Issue:11 Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Bacteria; Bacterial Infection	1988
Clinical efficacy of carumonam. Drugs under experimental and clinical research, 1988, Volume: 14, Issue:10 Topics: Aged; Aged, 80 and over; Aztreonam; Bacterial Infections; Female; Gram-Negative Aerobic Bacteria; Hu	1988
In-vitro susceptibility to aztreonam. The Malaysian journal of pathology, 1988, Volume: 10 Topics: Aztreonam; Bacterial Infections; Drug Resistance, Microbial; Gram-Negative Aerobic Bacteria; Humans;	1988
[Treatment with aztreonam of gram negative infections in patients seropositive for HIV]. Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques, 1988, Volume: 10, Issue:4 Topics: Adult; Aztreonam; Bacterial Infections; Female; Gram-Negative Bacteria; HIV Seropositivity; Humans;	1988
[Aztreonam in infections caused by gram-negative aerobic bacilli]. Revista medica de Panama, 1988, Volume: 13, Issue:1 Topics: Adolescent; Adult; Aged; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Gram-Negative Aer	1988
Antibiotic choices for the penicillin-allergic patient. Postgraduate medicine, 1988, Volume: 83, Issue:4 Topics: Animals; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cephalosporins; Cross Reactions; Dr	1988
Clinical evaluation of aztreonam for serious gram-negative bacterial infections. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1988, Volume: 7, Issue:1 Topics: Adult; Aged; Aztreonam; Bacterial Infections; Bone Diseases; Drug Evaluation; Female; Gastrointestin	1988
Aztreonam in the treatment of serious gram-negative infections in the elderly. International journal of clinical pharmacology, therapy, and toxicology, 1988, Volume: 26, Issue:1 Topics: Aged; Aged, 80 and over; Aztreonam; Bacterial Infections; Female; Gram-Negative Aerobic Bacteria; Hu	1988
Aztreonam treatment of sepsis. Scandinavian journal of infectious diseases, 1988, Volume: 20, Issue:3 Topics: Adolescent; Adult; Aged; Aztreonam; Bacterial Infections; Cross Infection; Female; Humans; Male; Mid	1988
Pharmacokinetics of aztreonam in very low birthweight neonates. European journal of clinical microbiology, 1987, Volume: 6, Issue:6 Topics: Aztreonam; Bacterial Infections; Humans; Infant, Low Birth Weight; Infant, Newborn	1987
[Clinical study of carumonam]. The Japanese journal of antibiotics, 1987, Volume: 40, Issue:11 Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Female; Humans; Infusions, Intr	1987
Aztreonam: therapy for infections in cancer patients. New Jersey medicine : the journal of the Medical Society of New Jersey, 1986, Volume: Spec No Topics: Antineoplastic Agents; Aztreonam; Bacterial Infections; Humans; Kinetics; Neoplasms; Neutropenia	1986
Aztreonam: an appraisal. New Jersey medicine : the journal of the Medical Society of New Jersey, 1986, Volume: Spec No Topics: Aztreonam; Bacteria; Bacterial Infections; beta-Lactamases; Drug Resistance, Microbial; Humans	1986
Aztreonam for severe infections. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl Topics: Aztreonam; Bacterial Infections; Female; Humans; Male; Middle Aged; Sepsis; Urinary Tract Infections	1987
Aztreonam in the therapy of severe gram-negative infections. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl Topics: Aztreonam; Bacterial Infections; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Surgic	1987
Aztreonam in gram-negative infections in children. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl Topics: Aztreonam; Bacterial Infections; Child; Child, Preschool; Female; Gram-Negative Bacteria; Humans; In	1987
[Aztreonam in severe gram-negative infections in hospitalized patients. Clinical experience in Spain. Preliminary data]. Medicina clinica, 1987, Apr-04, Volume: 88, Issue:13 Topics: Adolescent; Adult; Aged; Aztreonam; Bacterial Infections; Cross Infection; Female; Gram-Negative Bac	1987
Efficacy of aztreonam in pulmonary exacerbations of cystic fibrosis. The Pediatric infectious disease journal, 1987, Volume: 6, Issue:4 Topics: Adolescent; Adult; Aztreonam; Bacterial Infections; Child; Cystic Fibrosis; Female; Humans; Lung Dis	1987
[Clinical evaluation of aztreonam in the prevention and therapy of infections in patients subjected to neurosurgical intervention]. Minerva medica, 1987, Aug-31, Volume: 78, Issue:16 Topics: Adult; Aged; Aztreonam; Bacterial Infections; Child; Child, Preschool; Drug Administration Schedule;	1987
Pharmacokinetics of aztreonam in infected patients. The Journal of antimicrobial chemotherapy, 1986, Volume: 17, Issue:2 Topics: Adult; Aged; Aztreonam; Bacterial Infections; Creatinine; Female; Gram-Negative Bacteria; Half-Life;	1986
Effects of aztreonam and netilmicin upon alveolar macrophage function. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1986, Volume: 5, Issue:2 Topics: Acid Phosphatase; Aztreonam; Bacterial Infections; Humans; L-Lactate Dehydrogenase; Macrophages; Net	1986
Aztreonam therapy for serious gram-negative infections in children. American journal of diseases of children (1960), 1986, Volume: 140, Issue:11 Topics: Aztreonam; Bacteria, Aerobic; Bacterial Infections; Child, Preschool; Humans; Infant; Infant, Newbor	1986
Treatment of infections during hematologic malignancies with aztreonam, a new antibiotic. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1986, Volume: 5, Issue:6 Topics: Acute Disease; Aztreonam; Bacterial Infections; Humans; Leukemia; Lymphoma	1986
Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections. Archives of internal medicine, 1987, Volume: 147, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Aztreonam; Bacterial Infections; Female; Gram-Negative Bacteria; Hum	1987
[Fundamental and clinical studies on aztreonam in obstetrics and gynecology]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adolescent; Adult; Aged; Aztreonam; Bacteria; Bacterial Infections; Drug Evaluation; Drug Resistance	1985
[Preclinical and clinical studies on aztreonam in obstetrics and gynecology]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adult; Aged; Aztreonam; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Female; Genital	1985
[Clinical effect of aztreonam in infections in obstetrics and gynecology]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adult; Aged; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Female; Gen	1985
[Clinical studies on aztreonam in various infections in obstetrics and gynecology]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adult; Aged; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Female; Hum	1985
[Preclinical and clinical studies on aztreonam in the field of obstetrics and gynecology]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adult; Aged; Aztreonam; Bacteria; Bacterial Infections; Drug Evaluation; Drug Resistance, Microbial;	1985
[Clinical evaluation of aztreonam in the field of obstetrics and gynecology]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adolescent; Adult; Aged; Aztreonam; Bacteria; Bacterial Infections; Drug Evaluation; Drug Resistance	1985
[Tissue penetration and clinical experiences of aztreonam in obstetrics and gynecology]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adult; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Female; Genitalia	1985
[Basic and clinical studies of aztreonam in the field of obstetrics and gynecology]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adult; Aged; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Female; Hum	1985
[Clinical experience on aztreonam]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adult; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Female; Humans; M	1985
[Fundamental and clinical studies on aztreonam in the field of obstetrics and gynecology]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adult; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Female; Genitalia	1985
[Clinical trial of aztreonam in the field of obstetrics and gynecology]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adult; Aged; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Female; Hum	1985
[Fundamental and clinical studies on aztreonam in the gynecological field]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adult; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Female; Genitalia	1985
[Fundamental and clinical studies on aztreonam in the field of obstetrics and gynecology]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adult; Aztreonam; Bacterial Infections; Drug Evaluation; Exudates and Transudates; Female; Genital D	1985
[In vitro activity and clinical evaluation of aztreonam in the field of obstetrics and gynecology]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adult; Aztreonam; Bacteria; Bacterial Infections; Drug Evaluation; Drug Resistance, Microbial; Femal	1985
[Fundamental and clinical studies on aztreonam in the field of obstetrics and gynecology]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adult; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Female; Genitalia	1985
[Fundamental and clinical studies of aztreonam in the field of obstetrics and gynecology]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adult; Aged; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Female; Gen	1985
[Fundamental and clinical studies on aztreonam in the field of obstetrics and gynecology]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adult; Aged; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Female; Gen	1985
[Fundamental and clinical studies on aztreonam in the field of obstetrics and gynecology]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adult; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Female; Genitalia	1985
[Fundamental and clinical studies on aztreonam]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adolescent; Adult; Aged; Aztreonam; Bacterial Infections; Drug Evaluation; Exudates and Transudates;	1985
[Clinical studies on aztreonam in infections in obstetrics and gynecology]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adult; Aged; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Humans; Infusions, Parenteral	1985
[Clinical experience with aztreonam in the field of obstetrics and gynecology]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adolescent; Adult; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Femal	1985
[Clinical evaluation of aztreonam in the field of obstetrics and gynecology]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adult; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Female; Humans; M	1985
[Fundamental and clinical studies on aztreonam in obstetrics and gynecology]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adult; Aged; Amniotic Fluid; Aztreonam; Bacterial Infections; Exudates and Transudates; Female; Feta	1985
Evaluation of aztreonam in the treatment of severe bacterial infections. Antimicrobial agents and chemotherapy, 1985, Volume: 28, Issue:2 Topics: Adolescent; Adult; Aged; Aztreonam; Bacterial Infections; Child; Humans; Middle Aged; Osteomyelitis;	1985
[Clinical review and antibacterial effect of aztreonam in infections in obstetrics and gynecology]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12 Topics: Adult; Aztreonam; Bacteria; Bacterial Infections; Drug Evaluation; Drug Resistance, Microbial; Femal	1985
Aztreonam in the treatment of soft tissue infections including diabetic foot infections. Boletin de la Asociacion Medica de Puerto Rico, 1985, Volume: 77, Issue:5 Topics: Aged; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Diabetes Complications; Gram-Negative	1985
Aztreonam: the first monobactam. The American journal of medicine, 1985, Feb-08, Volume: 78, Issue:2A Topics: Animals; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Bacterial Proteins; beta-Lactamases	1985
In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic. Antimicrobial agents and chemotherapy, 1985, Volume: 27, Issue:5 Topics: Animals; Anti-Bacterial Agents; Aztreonam; Bacteria; Bacterial Infections; beta-Lactamases; beta-Lac	1985
Aztreonam therapy for gram-negative pneumonia. The American journal of medicine, 1985, Feb-08, Volume: 78, Issue:2A Topics: Adult; Aged; Alcoholism; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cross Infection; Dr	1985
Antimicrobial combinations in the therapy of infections due to gram-negative bacilli. The American journal of medicine, 1985, Feb-08, Volume: 78, Issue:2A Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Bacterial Proteins	1985
Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa. The American journal of medicine, 1985, Volume: 78, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Arthritis, Infectious; Aztreonam; Bacterial Infectio	1985
Treatment of gram-negative infections with aztreonam. The American journal of medicine, 1985, Feb-08, Volume: 78, Issue:2A Topics: Abscess; Adult; Aged; Anti-Bacterial Agents; Arthritis, Infectious; Aztreonam; Bacterial Infections;	1985
Efficacy and safety of aztreonam versus tobramycin for aerobic gram-negative bacilli lower respiratory tract infections. The American journal of medicine, 1985, Feb-08, Volume: 78, Issue:2A Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Drug Administration Schedule; Drug Evaluatio	1985
Aztreonam plus clindamycin as therapy for pelvic infections in women. The American journal of medicine, 1985, Feb-08, Volume: 78, Issue:2A Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Clindamycin; Drug Evaluation; Drug Th	1985
Current state of infectious diseases--potential areas of directed therapy with aztreonam. The American journal of medicine, 1985, Feb-08, Volume: 78, Issue:2A Topics: Abdomen; Anti-Bacterial Agents; Arthritis, Infectious; Aztreonam; Bacterial Infections; Biliary Trac	1985
Pharmacokinetics of aztreonam in patients with gram-negative infections. Antimicrobial agents and chemotherapy, 1985, Volume: 27, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Blood Proteins; Female; Gram-Ne	1985
[Evaluation of azthreonam in the treatment of severe infections: study of 17 cases]. Medicina clinica, 1985, Jun-08, Volume: 85, Issue:2 Topics: Aged; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Colon; Drug Evaluation; Female; Humans	1985
[Clinical studies on aztreonam following intravenous drip infusion]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:10 Topics: Adolescent; Adult; Aged; Aztreonam; Bacteria; Bacterial Infections; Drug Evaluation; Drug Resistance	1985
[Therapeutic effectiveness of aztreonam on severe infections associated with hematologic disorders. Hanshin Infection Study Group]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:9 Topics: Adolescent; Adult; Aged; Aztreonam; Bacterial Infections; Drug Evaluation; Drug Resistance, Microbia	1985
[Clinical and pharmacokinetic evaluations of aztreonam in children]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:11 Topics: Age Factors; Aztreonam; Bacterial Infections; Child; Child, Preschool; Drug Evaluation; Female; Huma	1985
[Fundamental and clinical studies on aztreonam in pediatrics]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:11 Topics: Adolescent; Age Factors; Aztreonam; Bacterial Infections; Blood Coagulation; Child; Child, Preschool	1985
[Fundamental and clinical studies of aztreonam in the field of pediatric]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:11 Topics: Age Factors; Aztreonam; Bacteria; Bacterial Infections; Child; Child, Preschool; Drug Evaluation; Dr	1985
[Fundamental and clinical studies of aztreonam in pediatric infections]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:11 Topics: Age Factors; Aztreonam; Bacteria; Bacterial Infections; Child, Preschool; Drug Evaluation; Drug Resi	1985
[Fundamental and clinical studies on aztreonam in the pediatric field]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:11 Topics: Age Factors; Aztreonam; Bacteria; Bacterial Infections; Child; Child, Preschool; Drug Evaluation; Dr	1985
[Laboratory and clinical studies of aztreonam in the pediatric field]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:11 Topics: Age Factors; Aztreonam; Bacteria; Bacterial Infections; Child; Child, Preschool; Drug Evaluation; Dr	1985
[Clinical evaluation of aztreonam in pediatrics]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:11 Topics: Age Factors; Aztreonam; Bacterial Infections; Child; Child, Preschool; Drug Evaluation; Female; Half	1985
[Clinical evaluation of aztreonam in children]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:11 Topics: Adolescent; Age Factors; Aztreonam; Bacteria; Bacterial Infections; Child; Child, Preschool; Drug Ev	1985
[Pharmacokinetics and clinical evaluation of aztreonam in pediatrics]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:11 Topics: Adolescent; Age Factors; Aztreonam; Bacteria; Bacterial Infections; Child; Child, Preschool; Drug Ev	1985
[Clinical evaluation on aztreonam in pediatric field and fundamental study on its penetration into cerebrospinal fluid]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:11 Topics: Adolescent; Age Factors; Aztreonam; Bacterial Infections; Child; Child, Preschool; Drug Evaluation;	1985
[Laboratory and clinical studies on aztreonam in the pediatric field]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:11 Topics: Age Factors; Aztreonam; Bacterial Infections; Child; Child, Preschool; Drug Evaluation; Drug Resista	1985
[Clinical efficacy of aztreonam in refractory infections in children]. The Japanese journal of antibiotics, 1985, Volume: 38, Issue:11 Topics: Adolescent; Adult; Age Factors; Aztreonam; Bacterial Infections; Child; Child, Preschool; Drug Evalu	1985

aztreonam and Bacterial Disease